FIELD: pharmacology.
SUBSTANCE: invention relates to application of adamantane-containing indoles and their hydrochlorides of general formula
where R1, R2, R3, R4 may be the same or different and independently represent H, F, Cl, Br, (C1-C6) alkyl, (C1-C6) alkoxy; R5, R6 may be the same or different and independently represent H, (C1-C6) alkyl, ONO2; X represents CH2CH(OH)CH2 or CH2CH2C(O); Z=no, Cl; R7, R8, R9, R10 may be the same or different and independently represent H, F, Cl, Br, (C1-C6) alkyl, (C1-C6) alkoxy; R11, R12, R13, R14, R15, R16, R17, R18 may be the same or different and independently represent H, (C1-C6) alkyl, as a cholinesterase inhibitors and NMDA receptors blockers, and can be used as new drugs that interact with several targets responsible for improval of memory and cognitive functions, weakening of which has various origin, including dementias of various origins, especially due to neurodegenerative diseases, such as Alzheimer's disease.
EFFECT: increased compound application effeciency.
15 cl, 1 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF ADAMANTANE-CONTAINING INDOLES AND THEIR HYDROCHLORIDES AS CYTOPROTECTORS AND FOR TREATING AND PREVENTING DISEASES ASSOCIATED WITH INCREASE IN CYTOSOLIC CALCIUM CONCENTRATION AND PHARMACOLOGICAL AGENT BASED THEREON | 2015 |
|
RU2608737C1 |
| ADAMANTANE-CONTAINING INDOLES AND THEIR HYDROCHLORIDES WITH MICROTUBULES STABILIZING PROPERTY, METHODS OF THEIR PRODUCTION, PHARMACOLOGICAL AGENT BASED THEREON AND METHOD OF TREATING AND PREVENTING DISEASES ASSOCIATED WITH MICROTUBULE SYSTEM DISORDERS | 2015 |
|
RU2608631C1 |
| DERIVATIVES OF 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE-CONTAINING PHENOTHIAZINES AS INHIBITORS OF CHOLINESTERASES AND BLOCKERS OF SEROTONIN RECEPTORS 5-HT, METHODS OF OBTAINING THEIR CHLOROHYDRATES AND BASED ON THEM PHARMACEUTICAL PREPARATION | 2013 |
|
RU2530881C1 |
| MULTIFUNCTIONAL CONJUGATES OF TACRINE AND ITS ANALOGUES WITH DERIVATIVES OF 1,2,4-TIADIAZOLE, THE WAY OF THEIR SYNTHESIS AND APPLICATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2017 |
|
RU2675794C1 |
| DEVICES FOR BLOOD INTAKE, CONTAINING LYSOPHOSPHOLIPASE INHIBITOR | 2012 |
|
RU2623049C2 |
| BIS[(3,5-DIMETHYLADAMANTY-1-YL)AMINO]ALKANES, HYDROCHLORIDES THEREOF, HAVING PROPERTY OF BLOCKERS OF TWO SITES OF NMDA-RECEPTORS, AND METHODS FOR PRODUCTION THEREOF | 2023 |
|
RU2838995C1 |
| TARGET DRUG WITH NEW COMPOSITIONS, COMBINATIONS AND METHODS | 2018 |
|
RU2760558C2 |
| MULTIFUNCTIONAL CONJUGATES OF IPIDACRINE WITH 2-SUBSTITUTED PHENOLS, METHOD FOR PRODUCTION THEREOF AND USE FOR TREATING NEURODEGENERATIVE DISEASES | 2023 |
|
RU2836319C1 |
| PIPERIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATION BASED ON THEREOF | 1997 |
|
RU2184112C2 |
| PHENOTHIAZINE-CONTAINING 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE DERIVATIVES AS AGENT FOR REDUCING UNCONTROLLED PROTEIN AGGREGATION IN NERVOUS SYSTEM, METHODS FOR PRODUCTION THEREOF, PHARMACOLOGICAL AGENT BASED THEREON AND METHOD OF REDUCING UNCONTROLLED PROTEIN AGGREGATION IN NERVOUS SYSTEM | 2013 |
|
RU2529899C1 |
